100 related articles for article (PubMed ID: 22975650)
1. Significance of surgical treatment in multimodal therapy for stage IV highly advanced gastric cancer.
Yabusaki H; Nashimoto A; Matsuki A; Aizawa M
Hepatogastroenterology; 2013; 60(122):377-81. PubMed ID: 22975650
[TBL] [Abstract][Full Text] [Related]
2. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
3. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer].
Funaki H; Fujita J; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1615-7. PubMed ID: 24393866
[TBL] [Abstract][Full Text] [Related]
5. [Conversion therapy of stage IV gastric cancer].
Tanizawa Y; Terashima M; Tokunaga M; Bando E; Kawamura T; Sugisawa N; Miki Y; Makuuchi R; Yamakawa Y; Kinugasa Y; Kanemoto H; Uesaka K; Yasui H
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2469-73. PubMed ID: 23235167
[TBL] [Abstract][Full Text] [Related]
6. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
7. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
8. [Examination of outcomes after conversion surgery for Stage IVGastric cancer in our hospital].
Hagino S; Kurata T; Makita N; Tsuneda A; Iwata K; Kiriyama M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2293-5. PubMed ID: 25731500
[TBL] [Abstract][Full Text] [Related]
9. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
[TBL] [Abstract][Full Text] [Related]
11. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.
Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996
[TBL] [Abstract][Full Text] [Related]
13. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis after surgical treatment of gastric cancer: review of 121 cases.
Nazli O; Derici H; Tansug T; Yaman I; Bozdag AD; Isgüder AS; Bölükbasi H
Hepatogastroenterology; 2007 Mar; 54(74):625-9. PubMed ID: 17523337
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
[TBL] [Abstract][Full Text] [Related]
17. Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM.
An JY; Ha TK; Noh JH; Sohn TS; Kim S
Arch Surg; 2009 Jan; 144(1):38-45; discussion 45. PubMed ID: 19153323
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
[TBL] [Abstract][Full Text] [Related]
19. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
20. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
